Recent

% | $
Quotes you view appear here for quick access.

Arena Pharmaceuticals, Inc. Message Board

  • zilanewswatch zilanewswatch Jul 11, 2013 1:19 PM Flag

    Summer Street has raised its price target on Avanir to $16 from $14

    July 8, 2013
    Avanir Pharmaceuticals (NASDAQ:AVNR): Summer Street has raised its price target on Avanir to $16 from $14 following the company’s deal with OptiNose AS. It keeps a Buy ratings on the shares.

    Sentiment: Strong Buy

 
ARNA
4.08+0.09(+2.26%)Jul 28 4:00 PMEDT